Today's Low
₹ 1,237.25
Today's High
₹ 1,262.90
52 Weeks Low
₹ 1,045.00
52 Weeks High
₹ 2,288.80
Lower
₹ 995.00
Upper
₹ 1,492.50
Astec LifeSciences Limited, together with its subsidiaries, manufactures, distributes, and sells agrochemicals active ingredients and pharmaceutical intermediates in India. The company manufactures a range of fungicides, insecticides, herbicides, and intermediates, such as triazole fungicides, heterocyclic herbicides, sulfonyl urea herbicides, synthetic pyrethroids, alkyl and aryl magnesium halides, mixed metal halides, and silane derivatives; fluorinated aromatic amines, pyridine derivatives, aromatic carboxylic acids, benzyl alcohols, ketones and benzophenones, and heterocyclic mercaptans; fluorinated aromatic, aliphatic, and heterocyclic intermediates; heterocyclic mercaptans, thiopyrimidines, aromatic mercaptans, heterocyclic sulfonyl chlorides, heterocyclic sulphonamides, heterocyclic carbamates, thiourium salts, alkyl and aryl chloroformates, substituted pyrimidine diones, and pyrazolones; and substituted 1,2- and 1,3- pyrimidines. Its products also comprise pyrazolyl aromatic ketones, morpholine derivatives, aromatic azo compounds, substituted triazines, imidate ethers, mesylated intermediates, substituted epoxides, ketals and bromo ketals, aromatic and aliphatic ethers, cyclopropyl ethers, cyclopropyl aldehydes and ketones, conjugated ketones, acetophenone derivatives, pinacolone derivatives, aliphatic and aromatic carboxylic acids, aliphatic and aromatic acid chlorides, halogenated and non-halogenated anhydrides, aliphatic alkenes, and halo alkanes; and aliphatic and aromatic brominated derivatives, cyanides, esters, carboxamides, amines, and alcohols and diols. The company also exports its products. Astec LifeSciences Limited was incorporated in 1994 and is based in Mumbai, India. Astec LifeSciences Limited is a subsidiary of Godrej Agrovet Limited.
No of shares Outstanding
EPS-TTM
Face Value
Book Value
Net Asset Value
ROE
ROA
ROCE
Dividend Yield
Total Debt
Sales Growth
PAT Growth
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 498.9 | 515.7 | 330.4 | 331.8 | 248.5 | 231.7 | 198.4 | 191.2 | 203.5 | 134.9 | 118.6 | 108.3 |
Total Non-Current Assets | 480.6 | 409.7 | 347.2 | 240.0 | 212.6 | 181.5 | 135.2 | 136.4 | 158.4 | 149.6 | 142.5 | 123.1 |
Total Assets | 979.4 | 925.4 | 677.6 | 571.7 | 461.1 | 413.2 | 333.6 | 327.6 | 361.9 | 284.5 | 261.1 | 231.4 |
Total Current Liabilities | 526.2 | 490.6 | 322.3 | 318.4 | 248.8 | 238.4 | 193.7 | 203.0 | 177.6 | 117.2 | 102.3 | 96.5 |
Total Non-Current Liabilities | 33.7 | 38.1 | 46.0 | 6.5 | 9.5 | 4.9 | 1.7 | 6.5 | 48.9 | 53.8 | 52.9 | 36.3 |
Shareholder's Funds | 419.4 | 396.5 | 309.2 | 246.6 | 202.5 | 169.7 | 138.0 | 118.0 | 135.3 | 113.5 | 105.8 | 98.5 |
Total Liabilities | 979.4 | 925.4 | 677.6 | 571.7 | 461.1 | 413.2 | 333.6 | 327.6 | 361.9 | 284.5 | 261.1 | 231.4 |
The Industry Price to BV stands at 4.75, vs the Price to BV of 6.57, which results in a Positive aspect.
The Industry Debt to Equity Ratio stands at 0.39, vs the Debt to Equity Ratio of 0.40, which results in a Negative aspect.
The Industry Quick Ratio stands at 1.58, vs the Quick Ratio of 0.66, which results in a Negative aspect.
The Industry Current Ratio stands at 2.23, vs the Current Ratio of 1.04, which results in a Negative aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Income | 628.2 | 676.6 | 554.9 | 522.6 | 430.9 | 367.6 | 298.7 | 247.0 | 266.9 | 207.0 | 174.8 | 112.8 |
Total Expenditure | 551.9 | 522.5 | 443.4 | 437.4 | 354.4 | 298.8 | 236.3 | 215.4 | 212.8 | 171.6 | 147.8 | 97.4 |
Operating Profit(Excl OI) | 89.3 | 164.5 | 119.5 | 97.1 | 87.6 | 76.9 | 65.3 | 38.8 | 55.1 | 35.7 | 28.1 | 16.1 |
Add: Other Income | 13.1 | 10.5 | 8.0 | 11.9 | 11.2 | 8.1 | 2.9 | 7.2 | 0.9 | 0.4 | 1.1 | 0.6 |
Operating Profit | 89.3 | 164.5 | 119.5 | 97.1 | 87.6 | 76.9 | 65.3 | 38.8 | 55.1 | 35.7 | 28.1 | 16.1 |
Less: Interest | 20.7 | 9.1 | 4.8 | 12.6 | 12.4 | 10.7 | 12.2 | 12.8 | 12.8 | 9.3 | 7.5 | 5.7 |
PBDT | 68.6 | 155.5 | 114.7 | 84.5 | 75.3 | 66.2 | 53.0 | 26.0 | 42.2 | 26.5 | 20.6 | 10.5 |
Less: Depreciation Amortization | 33.7 | 34.4 | 25.7 | 23.2 | 19.4 | 14.7 | 13.7 | 10.4 | 12.7 | 14.8 | 11.9 | 8.6 |
PBT & Exceptional Items | 35.0 | 121.1 | 89.1 | 61.4 | 55.9 | 51.6 | 39.4 | 15.6 | 29.5 | 11.7 | 8.7 | 1.8 |
Less: Exceptional Income Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 4.2 | -10.6 | -3.2 | -16.9 | -0.6 | 0.0 | 0.0 |
Profit Before Tax | 35.0 | 121.1 | 89.1 | 61.4 | 55.9 | 55.7 | 28.7 | 12.4 | 12.6 | 11.2 | 8.7 | 1.8 |
Less: Taxation | 9.4 | 31.2 | 24.0 | 13.8 | 20.1 | 20.7 | 9.6 | 7.4 | -2.2 | 2.5 | 2.8 | 0.5 |
Profit After Tax | 25.6 | 89.9 | 65.1 | 47.5 | 35.8 | 35.0 | 19.2 | 5.1 | 14.8 | 8.7 | 5.9 | 1.3 |
Earnings Per Share | 0.1 | 0.5 | 0.3 | 0.2 | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
The Industry Dividend Yield stands at 0.78, vs the Dividend Yield of 0.12, which results in a Negative aspect.
The Industry PAT Growth stands at 31.52, vs the PAT Growth of 32.89, which results in a Positive aspect.
The Industry PAT Margin stands at 11.47, vs the PAT Margin of 9.04, which results in a Negative aspect.
The Industry PE Ratio stands at 30.15, vs the PE Ratio of 0.00, which results in a Negative aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Profit Before Tax | 34.9 | 121.1 | 89.1 | 61.4 | 55.9 | 55.7 | 28.7 | 12.4 | 19.0 | 11.1 | 8.7 | 1.9 |
Tax Paid | -4.9 | -29.1 | -23.0 | -18.2 | -16.4 | -15.4 | -6.7 | -5.0 | -2.6 | -1.9 | -1.5 | -1.0 |
Adjustment | 50.5 | 44.0 | 29.1 | 37.5 | 30.3 | 17.9 | 34.8 | 18.8 | 23.3 | 22.4 | 17.3 | 14.2 |
Changes In Working Capital | 34.9 | 121.1 | 89.1 | 61.4 | 55.9 | 55.7 | 28.7 | 12.4 | 19.0 | 11.1 | 8.7 | 1.9 |
Cash Flow after changes in Working Capital | 79.5 | 52.8 | 14.8 | 186.7 | 31.7 | 80.0 | 25.9 | -7.6 | 10.1 | 16.5 | 17.9 | 9.7 |
Cash Flow from Operating Activities | 74.7 | 23.6 | -8.2 | 168.4 | 15.3 | 64.7 | 19.2 | -12.5 | 7.5 | 14.6 | 16.4 | 8.6 |
Cash Flow from Investing Activities | -112.5 | -103.9 | -73.1 | -73.8 | -52.5 | -48.9 | -17.7 | -16.1 | -19.2 | -18.7 | -13.3 | -50.0 |
Cash Flow from Financing Activities | 37.8 | 80.5 | 81.3 | -94.5 | 37.1 | -18.2 | -0.9 | 30.7 | 11.7 | 3.4 | -2.1 | 42.4 |
Net Cash Inflow / Outflow | -0.1 | 0.2 | 0.1 | 0.1 | -0.1 | -2.5 | 0.6 | 2.1 | -0.1 | -0.7 | 1.0 | 1.0 |
Opening Cash & Cash Equivalents | 0.6 | 0.3 | 0.3 | 0.2 | 0.3 | 2.8 | 2.2 | 0.7 | 0.8 | 5.1 | 4.1 | 3.1 |
Closing Cash & Cash Equivalent | 0.5 | 0.6 | 0.3 | 0.3 | 0.2 | 0.3 | 2.8 | 2.2 | 0.7 | 4.5 | 5.1 | 4.1 |
The Industry PCF RATIO stands at 30.01, vs the PCF RATIO of 4.65, which results in a Negative aspect.
The Industry PFCF Ratio stands at 14.68, vs the PFCF Ratio of 6.91, which results in a Negative aspect.
Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 507.9 | 1,107.9 | 1,428.5 | 1,269.7 | 1,171.8 | 1,997.5 | 1,842.7 | 2,719.8 | 1,733.5 | 1,025.7 | 1,286.6 | 1,719.2 | 1,160.1 | 1,550.0 | 1,119.4 | 1,805.7 |
Total Income | 517.0 | 1,117.7 | 1,445.6 | 1,295.5 | 1,209.7 | 2,037.3 | 1,869.8 | 2,787.9 | 1,753.1 | 1,034.7 | 1,294.6 | 1,734.7 | 1,192.8 | 1,568.5 | 1,132.0 | 1,858.1 |
Total Expenditure | 691.3 | 1,142.1 | 1,397.2 | 1,215.7 | 1,050.6 | 1,664.7 | 1,588.2 | 2,065.2 | 1,304.9 | 814.9 | 1,039.9 | 1,337.3 | 1,004.3 | 1,255.0 | 836.7 | 1,378.8 |
PBIDT (Excl OI) | -183.3 | -34.2 | 31.3 | 54.0 | 121.2 | 332.8 | 254.5 | 654.6 | 428.6 | 210.8 | 246.7 | 381.9 | 155.8 | 295.1 | 282.8 | 426.9 |
Other Income | 9.1 | 9.8 | 17.1 | 25.8 | 37.9 | 39.9 | 27.1 | 68.1 | 19.6 | 9.0 | 8.0 | 15.5 | 32.7 | 18.5 | 12.5 | 52.4 |
Operating Profit | -174.2 | -24.4 | 48.4 | 79.8 | 159.1 | 372.7 | 281.6 | 722.7 | 448.2 | 219.8 | 254.7 | 397.4 | 188.5 | 313.5 | 295.3 | 479.3 |
Interest | 61.0 | 59.9 | 64.6 | 64.0 | 58.8 | 45.1 | 39.2 | 33.2 | 25.6 | 16.5 | 15.3 | 10.4 | 10.6 | 11.3 | 15.3 | 21.5 |
Exceptional Items | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
PBDT | -235.2 | -84.4 | -16.2 | 15.8 | 100.4 | 327.5 | 242.4 | 689.4 | 422.7 | 203.3 | 239.4 | 387.0 | 178.0 | 302.3 | 280.0 | 457.8 |
Depreciation | 87.0 | 91.6 | 93.9 | 77.6 | 88.0 | 81.7 | 89.3 | 106.4 | 90.6 | 81.5 | 65.1 | 65.3 | 65.2 | 63.4 | 62.6 | 61.5 |
Profit Before Tax | -322.2 | -176.0 | -110.1 | -61.8 | 12.4 | 245.8 | 153.1 | 583.0 | 332.1 | 121.8 | 174.4 | 321.8 | 112.8 | 238.8 | 217.4 | 396.3 |
Tax | -78.9 | -41.8 | -28.2 | -12.1 | 3.9 | 62.7 | 39.0 | 152.4 | 84.6 | 31.0 | 44.5 | 82.1 | 42.1 | 60.3 | 55.5 | 84.5 |
Provisions and contingencies | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit After Tax | -243.3 | -134.2 | -81.9 | -49.8 | 8.5 | 183.2 | 114.1 | 430.6 | 247.5 | 90.8 | 129.9 | 239.7 | 70.6 | 178.6 | 161.9 | 311.8 |
Net Profit | -243.3 | -134.2 | -81.9 | -49.8 | 8.5 | 183.2 | 114.1 | 430.6 | 247.5 | 90.8 | 129.9 | 239.7 | 70.6 | 178.6 | 161.9 | 311.8 |
ADDITIONAL INFOS: | ||||||||||||||||
Equity Capital | 196.1 | 196.1 | 196.1 | 196.1 | 196.1 | 196.1 | 196.0 | 196.0 | 195.9 | 195.9 | 195.9 | 195.9 | 195.8 | 195.8 | 195.7 | 195.7 |
Reserves | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
EPS | -12.4 | -6.9 | -4.2 | -2.5 | 0.4 | 9.3 | 5.8 | 22.0 | 12.6 | 4.6 | 6.6 | 12.2 | 3.6 | 9.1 | 8.3 | 15.9 |
Operating Profit Margin | -34.3 | -2.2 | 3.4 | 6.3 | 13.6 | 18.7 | 15.3 | 26.6 | 25.9 | 21.4 | 19.8 | 23.1 | 16.3 | 20.2 | 26.4 | 26.5 |
Net Profit Margin | -47.9 | -12.1 | -5.7 | -3.9 | 0.7 | 9.2 | 6.2 | 15.8 | 14.3 | 8.9 | 10.1 | 13.9 | 6.1 | 11.5 | 14.5 | 17.3 |
The Industry Mcap Growth stands at 343.80, vs the Mcap Growth of -25.68, which results in a Negative aspect.
The Industry Net Sales Growth stands at 22.13, vs the Net Sales Growth of 21.28, which results in a Negative aspect.
Type | Classic | Woodie | Camarilla |
---|---|---|---|
R4 | 1,345.20 | 1,413.95 | 1,254.14 |
R3 | 1,317.77 | 1,313.80 | 1,236.87 |
R2 | 1,290.33 | 1,288.35 | 1,231.11 |
R1 | 1,254.97 | 1,251.00 | 1,225.36 |
Pivot | 1,227.53 | 1,225.55 | 1,227.53 |
S1 | 1,192.17 | 1,188.20 | 1,213.84 |
S2 | 1,164.73 | 1,162.75 | 1,208.09 |
S3 | 1,129.37 | 1,125.40 | 1,202.33 |
S4 | 1,094.00 | 1,037.15 | 1,185.06 |
(All Values are in INR)
1 Day
1 Week
1 Month
Stoch RSI
23.46
Neutral
RSI
65.63
Neutral
ROC
10.23
Bullish
UltimateOscillator
48.70
Neutral
Williams Indicator
-30.58
Neutral
CCI Indicator
61.03
Neutral
MACD
-2,081.99
Bearish
Stochastic Indicator
65.66
Neutral
ATR
57.33
High Volatility
Ex-Date | Ratio | Record Date |
---|
Ex-Date | Ratio | Record Date |
---|---|---|
Announcement Date | Dividend Amount | Dividend Percentage of FV | Dividend Type |
---|---|---|---|
21-07-2023 | 1.50 | 15 | Final |
19-07-2022 | 1.50 | 15 | Final |
22-07-2021 | 1.50 | 15 | Final |
Date Of Conduct | Board Meeting Details |
---|---|
02-05-2024 | Audited Results |
25-01-2024 | Quarterly Results |
27-10-2023 | Quarterly Results & Inter alia, may also consider and approve enhancement in the existing limit of issuance of Debenture(s) or Debt Securities upto such limit as may be deemed appropriate by the Board, subject to such other approval(s) as may be applicable. |
27-07-2023 | Quarterly Results |
02-05-2023 | Audited Results & Final Dividend |
30-01-2023 | Quarterly Results Inter alia, the Board may also consider and approve issuance of Debentures or debt securities upto such limit as may be deemed appropriate and approved by the Board, subject to such other approval(s) as may be applicable. |
28-10-2022 | Quarterly Results |
25-07-2022 | Quarterly Results |
02-05-2022 | Audited Results & Final Dividend |
25-01-2022 | Quarterly Results |
27-10-2021 | Quarterly Results |
28-07-2021 | Quarterly Results |
30-04-2021 | Audited Results & Final Dividend |